Our findings that senescent cells can sensitize not yet fully transformed cells or unresponsive tumor cell lines to TRAIL provides a novel view on the interactomes of aging and cancer cells and may pave the way to novel therapeutic approaches. This evidence concerns the gene TNFSF10 and cancer.